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Rheumatologists are infamous for prescribing numer-
ous medications. When our patients talk about how doc-
tors in different department are overwhelmed by the loads
of medications, we rheumatologists share the same feel-
ings of guilt and indignation. Because of its progression
and unique nature, rheumatic diseases, such as rheuma-
toid arthritis, require multiple drug-regimen rather than
single drug regimen, even in the early stages. Hence, ini-
tial prescriptions of “strong” medications like immuno-
suppressant are common practice and important in lieu of
treatment guideline. It is not surprising to prescribe more
than 6 medications when we rheumatologist add anti-
inflammatory drugs, heart burn medications, and not to
mention rheumatologist’s “favorite” steroids. Moreover,
rheumatoid arthritis’ systemic complications like osteo-
porosis require even more additional prescriptions of cal-
cium and bisophosphonate. Having said that, the rheuma-
tologists are usually perceived as the “blind prescriber,”
even when they prescribe something that can alleviate
adverse effects like folic acid alleviating the methotrexate
adverse effect. Frequently, the total number of medica-
tions rheumatologists prescribe exceeds single digit.
When patients experience severe pain and totally depend
on their physicians, prescribing myriads of drugs poses no
problems. Ironically, the real problem arises as the
patients' pain is well controlled. Imagine the patients with
no apparent symptoms are looking at the pills in their
palm. Patients begin to doubt and begin to question their
prescriptions. “Will these medications make a nasty stom-
achache?” “I have heard that steroids are bad.” “Is it really
necessary to take these pain killers all at once?” This is
exactly when patients' compliance begins to decrease. This
is only the start as the real predicament arises. Because of
effects of the medication appear slowly over the period of
4-5 months, skipping the drugs for once or twice will not
change anything. In fact, forgetting taking medication
once or twice will not aggravate any symptoms. However,
as the patients habitually skip their medications, the
rheumatoid arthritis exacerbations can occur. Doctors
who do not recognize this prolonged poor compliance will
obviously add more drugs or substitute old prescriptions
with newer and stronger medications, thinking that old
medications do not work. 
Consider this. Symptom exacerbation and consistent
joint pain is acceptable because pain can do some good by
bringing more medical attention and by preventing
patients going astray from the therapy regimen. However,
alleviation of symptom can tempt patients not to take the
regular medications and creating the endless exacerba-
tion-alleviation loop, which can  cause the irreversible
damage to the joint structures and function.
Hence, it is strategically important to predict patient's
compliance to prevent patient's doubt and ultimately the
vicious cycle of exacerbation-alleviation, as I mentioned
above. Also, unnecessary prescription of expensive drugs
to prevent medical bills and demands are still in current
medical opinions. As early as 1990s', other countries took
initiative to take survey from the rheumatic patients in
DOI: 10.3904/kjim.2011.26.1.25
EDITORIAL
See Article on Page 28-33
EDITORIAL
Correspondence to Ji Hyeon Ju, M.D., Ph.D.
Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea School of Medicine, 505 Banpo-
dong, Seocho-gu, Seoul 137-040, Korea
Tel: 82-2-590-1429, Fax: 82-2-3476-2274, E-mail: juji@catholic.ac.kr26 The Korean Journal of Internal Medicine Vol. 26, No. 1, March 2011
order to estimate patients’ compliance and through some
clinical trials, it proved its efficacy in predicting the com-
pliance. For instance, the well-known patients' compli-
ance measures are Belief about Medications
Questionnaire (BMQ) [1] and Compliance Questionnaire-
Rheumatology (CQR) [2,3], which were developed in
England and in Netherland, respectively. The paper pub-
lished in this issue discusses the efficacy and validity of
Korean-version of CQR by Lee EB, et al. Questionnaire
based surveys contain questions that are unique to that
culture; that is, depending on location of the question-
naires, survey will unintentionally imbue some of the cul-
tural backgrounds. Hence, the very first step in the appli-
cation of questionnaire based survey into the Korean
rheumatology clinic is to modify the questionnaires to “fit”
into the Korean cultures. Having said that, the culturally
modified CQR, also known as the Korean CQR (KCQR),
appropriately corresponds with the original CQR, and it
will probably be useful in the real clinical settings in
Korea. 
I propose that in order to improve patients’ compliance,
the process must be in terms of before the treatment, dur-
ing the treatment, and after the treatment (Fig. 1).
Patient’s trust in medication plays a crucial role in influ-
encing the patients’ compliance. Some reports claim that
the trust in medications influence the patients’ compliance
more than socioeconomic factors and clinical factors com-
bined. Then, it is obvious that doubts in medication will
lower the needs for the medication and hence the compli-
ance. Recently, floods of incorrect information from the
internet have negatively influenced patients’ trust in med-
ication and compliance. It is our social responsibility to
correct the wrong information. When we treat patients,
we can utilize the KCQR and other means to predict the
compliance. We can study patient’s compliance so that we
can correct the misunderstandings patients may have and
formulate medications that optimize patients’ need as well
as patients’ compliance. Even after the prescription is
made, there are many way to follow up patients’ compli-
ance. One possibility to follow up their compliance is to
take advantage of current media; namely, text messaging,
internet social-networks like facebook, internet alert sys-
tem, and so on. This concept can be summarized by the
phrase “2C (concept, compliance) up, 2C (complication,
complaint) down” - this terms are not publicly accepted,
but just my thought. That is, patient’s correct concept of
medication will increase their compliance; thereby, reduc-
ing complication and complaint, thereof.  
Figure 1. Barrier to well-controlled taking medication in chronically ill patients such as rheumatoid arthritis.Ju JH. How to increase compliance in patients with rheumatoid arthritis? 27
In conclusion, one of the excerpts from the Lee EB et
al's KCQR touches my heart: “I do not expect miracles
from anti-rheumatic medications.” At first, when patients
are exhausted from severe pain, patients do expect mira-
cles from their medications; in other words, they have no
choice but to comply. However, once they experience the
“miracle,” perhaps, it is a human nature to forget; in other
words, they complain. I cannot help think about Jesus
Christ who performed many miracles but at the end,
betrayed by his own disciple Judas. (Korean J Intern
Med 2011;26:25-27)
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